PLEASANTON — 10x Genomics has marked a new phase in its remarkable expansion by opening a modern office building that has just sprouted in Pleasanton, coupled with plans for even more growth at its emerging campus.
The building is located near the corner of Stoneridge Mall Road and Springdale Avenue and totals 150,000 square feet, according to the biotech company.
“This new building will enable us to expand and scale the company,” said Ben Hindson, chief scientific officer and co-founder of 10x Genomics. “We are seeing increased orders and demand for our products.”
10x Genomics, whose Pleasanton headquarters are a short stroll from the new building, makes equipment, software, and other products that enable biomedical experts to analyze cells in greater detail and with more precision than before.
“Our products have enabled researchers to make fundamental discoveries across multiple areas of biology, including oncology, immunology, and neuroscience,” 10x Genomics stated in a prospectus for its IPO, which was launched in 2019.
In 2021, 10x Genomics set the stage for the big expansion of its campus with its purchase for $29.4 million in cash of a 14.6-acre retail site at 1701 Springdale Avenue. The biotech firm bulldozed the largely empty shopping center to make way for the construction of the first of multiple office buildings on that site.
The new building will accommodate laboratories and office space, according to Hindson.
10x Genomics also has offices in two buildings that it leases, at 6210 and 6230 Stoneridge Mall Road. Each of these two buildings totals 150,000 square feet. 10x Genomics occupies the entirety of the 6230 Stoneridge building and has all but one floor of the 6210 Stoneridge building — although it has the option to expand onto that floor.
“We are able to work together in this cutting-edge lab and facility,” Hindson said. “We really value the collaboration to create what we need to create.”
The company was founded in the garage of one of the co-founders, according to Hindson.
In 2015, 10x Genomics employed 110 people, according to its annual report filings with the Securities and Exchange Commission.
10x Genomics employed 584 workers worldwide at the end of 2019, 852 people at the end of 2020, 1,239 people at the end of 2021 and 1,243 at the end of 2022, the SEC filings showed.
“We have plenty of room to grow at our Pleasanton campus should we need that,” Hindson said. “We are always in hiring mode.”
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Technology News Click Here